Covered recipient · General Payments record
DOMINIC MUZSNAI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2019
$372.27
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $235.52 | 20 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $136.67 | 14 |
| Teva Pharmaceuticals USA, Inc. | $38.80 | 2 |
| Acerta Pharma LLC | $33.81 | 2 |
| GlaxoSmithKline, LLC. | $14.70 | 1 |
| Amarin Pharma Inc. | $11.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amarin Pharma Inc. | $11.54 | 02/28/2019 | Food and Beverage | Undisputed | 01/23/2026 | 699092441 | CMS |
| Amgen Inc. | $6.18 | 01/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308379 | CMS |
| Amgen Inc. | $7.45 | 02/06/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308371 | CMS |
| Amgen Inc. | $6.75 | 02/12/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308373 | CMS |
| Amgen Inc. | $5.83 | 02/20/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308375 | CMS |
| Amgen Inc. | $33.68 | 03/05/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308391 | CMS |
| Amgen Inc. | $6.26 | 03/18/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308381 | CMS |
| Amgen Inc. | $7.33 | 04/01/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308377 | CMS |
| Amgen Inc. | $25.04 | 04/02/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308369 | CMS |
| Amgen Inc. | $5.89 | 04/08/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308383 | CMS |
| Amgen Inc. | $7.12 | 04/29/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308385 | CMS |
| Amgen Inc. | $6.37 | 05/24/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308387 | CMS |
| Amgen Inc. | $5.04 | 05/30/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308389 | CMS |
| Amgen Inc. | $8.01 | 07/18/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308393 | CMS |
| Amgen Inc. | $5.72 | 07/25/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662308395 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.42 | 01/31/2019 | Food and Beverage | Undisputed | 01/23/2026 | 685729223 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.39 | 03/22/2019 | Food and Beverage | Undisputed | 01/23/2026 | 685192451 | CMS |
| GlaxoSmithKline, LLC. | $14.70 | 06/13/2019 | Food and Beverage | Undisputed | 01/23/2026 | 671108083 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.61 | 02/05/2019 | Food and Beverage | Undisputed | 01/23/2026 | 697781107 | CMS |
| Teva Pharmaceuticals USA, Inc. | $23.19 | 05/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | 697707695 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.